Induction of proinflammatory cytokine and antioxidant enzyme gene expression following brief myocardial ischaemia

Clinical and Experimental Immunology

Volumn 108, Issue 2, 1997, Pages 346-351

  Chandrasekar, B ^a   Colston, J T ^a   Freeman, G L ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

antioxidant enzymes; gene expression; ischaemia; proinflammatory cytokines; reperfusion injury

Indexed keywords

ANTIOXIDANT; CATALASE; CYTOKINE; GLUTATHIONE PEROXIDASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; SCAVENGER; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; GENE EXPRESSION REGULATION; HEART MUSCLE ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0030906936     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-1017.x     Document Type: Article

References (38)

1. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982; 66:1146-9.
2. Bolli R. Myocardial 'stunning' in man. Circulation 1992; 6:1671-91.
3. Bolli R. Oxygen-derived free radicals and postischemic myocardial dysfunction ('stunned myocardium'). J Am Coll Cardiol 1988; 12: 239-49.
4. Jeroudi MO, Triana FJ, Patel BS, Bolli R. Effect of superoxide dismutase and catalase, given separately, on myocardial 'stunning'. Am J Physiol 1990; 259:H889-H901.
5. Das DK, Prasad MR, Lu D, Jones RM. Preconditioning of heart by repeated stunning: adaptive modification of antioxidative defence system. Cell Mol Biol 1992; 38:739-49.
6. Das DK, Engleman RM, Kimura Y. Molecular adaptation of cellular defenses following preconditioning of the heart by repeated ischemia. Cardiovasc Res 1993; 27:578-84.
7. Tracey KJ, Vlassara H, Cerami A. Cachectin/tumor necrosis factor. N Engl J Med 1987; 316:379-85.
8. Beutler B, Cerami A. Cachectin: more than a tumor necrosis factor. Lancet 1989; 1:1112-26.
9. Murray DR, Freeman GL. Tumor necrosis factor-α induces a biphasic effect on myocardial contractility in conscious dogs. Circ Res 1996; 78:154-60.
10. Hosenpud JD, Campbell SM, Mendelson DJ. Interleukin-1-induced myocardial depression in an isolated beating heart preparation. J Heart Transplant 1989; 8:460-4.
11. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative ionotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257:387-9.
12. Laganiere S, Yu BP. Age-realted alterations in duodenal calcium transport rate in rats. Mech Ageing Dev 1989; 48:221-30.
13. 1 mice. Lipids 1994; 29:561-8.
14. Korc M, Chandrasekar B, Yamanaka Y, Friess H, Buechler M, Beger HG. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. J Clin Invest 1992; 90:1352-60.
15. Chandrasekar B, Freeman GL. Induction of proinflammatory cytokine expression in experimental acute Chagasic cardiomyopathy. Biochem Biophys Res Commun 1996; 223:365-71.
16. Chandrasekar B, McGuff HS, Aufdermorte TB, Troyer DA, Talal N, Fernandes G. Effects of calorie restriction on transforming growth factor β1 and proinflammatory cytokines in murine Sjögren's syndrome. Clin Immunol Immunopathol 1995; 76:291-6.
17. Knowlton AA, Brecher P, Apstein CS. Rapid expression of heat shock protein in the rabbit after brief cardiac ischemia. J Clin Invest 1991; 87:139-47.
18. Mestril R, Chi S-H, Sayan MR, Dillmann WH. Isolation of a novel inducible rat heat shock protein (HSP70) gene and its expression during ischemia/hypoxia and heat shock. Biochem J 1994; 298:561-9.
19. Herskowitz A, Choi S, Ansari AA, Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol 1995; 146:419-28.
20. Squadrito F, Altavilla D, Zingarelli B, Ioculano M, Calapai G, Campo GM, Miceli A, Caputi AP. Tumor necrosis factor involvement in myocardial ischemia-reperfusion injury. Eur J Pharmacol 1993; 237:223-30.
21. Baeuerle PA. The inducible transcription factor NF-κB: regulation by distinct subunits. Biochim Biophys Acta 1991; 1072:63-80.
22. Bomsztyk K, Rooney JW, Iwasaki T, Rachi NA, Dower SK, Sibley C. Evidence that interleukin-1 and phorbol esters activate NF-κB by different pathways: role of protein kinase C. Cell Reg 1991; 2:329-35.
23. Lieberman TA, Baltimore D. Activation of interleukin-6 gene expression through the NF-κB transcription factor. Mol Cell Biol 1990; 10:2327-34.
24. Kuprash DV, Udalova IA, Turetskaya RL, Rice NR, Nedospasov SA. Conserved κB element located downstream of tumor necrosis factor α gene: distinct NF-κB binding pattern and enhancer activity in LPS activated murine macrophages. Oncogene 1995; 11:97-106.
25. Brach MA, de Vos S, Arnold C, Grub H-J, Mertelsmann R, Hermann F. Leukotriene B4 transcriptionally activates interleukin-6 expression involving NF- κB and NF-IL6. Eur J Immunol 1992; 22:2705-11.
26. Le J, Vilcek J. Biology of disease. Tumor necrosis factor and interleukin-1: cytokines with multiple overlapping biological activities. Lab Invest 1987; 56:234-8.
27. Sedor JR. Cytokines and growth factors in renal injury. Semin Nephrol 1992; 12:428-40.
28. Nikolic-Paterson DJ, Lan HY, Hill PA, Atkins RC. Macrophages in renal injury. Kidney Int; 45:S79-S82.
29. Radake HH, Meier B, Topley N, Floge J, Habermehl GG, Resch K. Interleukin-1α and tumor necrosis factor-α induce oxygen radical production in mesangial cells. Kidney Int 1990; 37:767-75.
30. Osborn LS, Kunkel S, Nabel GJ. Tumor necrosis factor α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc Natl Acad Sci USA 1989; 86:2336-40.
31. Schreck R, Baeuerle PA. A role for oxygen radicals as second messengers. Trends Cell Biol 1991; 1:39-43.
32. Yamashita N, Nishida M, Hoshida S, Kuzuya T, Hori M, Taniguchi N, Kamada T, Tada M. Induction of manganese superoxide dismutase in rat cardiac myocytes increases tolerance to hypoxia 24 h after preconditioning. J Clin Invest 1994; 94:2193-9.
33. Ito Y, Hiraishi H, Razandi M, Terano A, Harada T, Ivey KJ. Role of cellular superoxide dismutase against reactive oxygen metabolite-induced cell damage in cultured rat hepatocytes. Hepatology 1992; 267:14812-7.
34. Hirose K, Longo DL, Openheim JJ, Matsushima K. Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation. FASEB J 1993; 7:361-8.
35. Visner GA, Dougall WC, Wilson JM, Burr IA, Nick HS. Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. J Biol Chem 1990; 265:2856-64.
36. Lin PS, Ho KC, Sung SJ, Tsai S. Cytotoxicity and manganese superoxide dismutase induction by tumor necrosis factor-α and ionizing radiation in MCF-7 human breast carcinoma cells. Lymph Cyto Res 1993; 12:303-8.
37. Kizaki M, Sakashita A, Karmakar A, Lin C-W, Koeffler HP. Regulation of manganese superoxide dismutase and other antioxidant genes in normal and leukemic hematopoitic cells and their relationship to cytotoxicity by tumor necrosis factor. Blood 1993; 82:1142-50.
38. 2 tolerance. Am J Physiol 1992; 263:L22-L26.